0001213900-21-005247.txt : 20210129 0001213900-21-005247.hdr.sgml : 20210129 20210129115450 ACCESSION NUMBER: 0001213900-21-005247 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 EFFECTIVENESS DATE: 20210129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cancer Prevention Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001471002 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262772394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-387825 FILM NUMBER: 21569599 BUSINESS ADDRESS: STREET 1: 1760 E RIVER ROAD #250 CITY: TUCSON STATE: AZ ZIP: 85718 BUSINESS PHONE: (520) 908-7774 MAIL ADDRESS: STREET 1: 1760 E RIVER ROAD #250 CITY: TUCSON STATE: AZ ZIP: 85718 FORMER COMPANY: FORMER CONFORMED NAME: Cancer Prevention Pharmaceuticals, LLC DATE OF NAME CHANGE: 20090826 D 1 primary_doc.xml X0708 D LIVE 0001471002 Cancer Prevention Pharmaceuticals, Inc. 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 520-908-7774 DELAWARE None Cancer Prevention Pharmaceuticals, LLC Corporation true Jeffrey Jacob 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Executive Officer Director John Saxe 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Director Eugene Gerner, Ph.D. 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Director While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. Richard Love 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Director Daniel Donovan 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Director Andrew Levitch 1760 EAST RIVER ROAD, SUITE 250 TUCSON AZ ARIZONA 85718 Executive Officer Biotechnology Decline to Disclose 06b false 2021-01-20 false true false 0 3000000 400000 2600000 false 6 0 0 0 While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers. false Cancer Prevention Pharmaceuticals, Inc. /s/ Jeffrey Jacob Jeffrey Jacob Chairman and Chief Executive Officer 2021-01-29